Forum Home | Log in | Signup | My Page | Rules | FAQ | Boards | Members | Search
« 6TH POPE Home | Email msg. | Reply to msg. | Post new | Board info. Previous | Home | Next

mRNA vaccines are less effective against the new strains. 

By: Decomposed in 6TH POPE | Recommend this post (3)
Sat, 20 Feb 21 6:50 AM | 60 view(s)
Boardmark this board | 6th Edition Pope Board 		Msg. 13008 of 58641
Jump:
Jump to board:
Jump to msg. #

Read: http://www.medicalnewstoday.com/articles/mrna-vaccines-may-provide-lower-immunity-to-new-sars-cov-2-variants

It's become apparent that the Moderna and Pfizer inoculants do not have the same rate of effectiveness against new strains as they do against the original. The hopes for that have been dashed. I've given you one article but a number are now circulating. The above article states that J&J and Novavax may have the same problem, but against DIFFERENT strains than the mRNA vaccines struggle with. The talk is that people will need to receive inoculation updates every six months in order to maintain their defenses against new strains that are going to be cropping up for the rest of eternity.

These drugs all introduce, directly or indirectly, spike protein strands into the body. None of them introduce COMPLETE strands. The strand fragments introduced by Moderna, Pfizer, J&J and Novavax are not the same. It's turning out that some of them, through sheer luck, work better than others against the variants of SARS-CoV-2.

Unfortunately, at this point there are a lot of strains. There's even one that evades antibodies. There's concern that vaccines may not work against it at all.

Our bodies have two levels of immune response. The higher level produces antibodies that fight off infection. The lower level REMEMBERS how to fight off infections that have already been experienced and allows it to mount a defense faster in the future if a repeat infection occurs. The reason both are needed is that it takes enormous energy to maintain antibodies, more than our bodies can afford, so antibodies die off after a little while allowing us to put our energy into other things such as muscle growth.

The reason I'm talking about this is that if we are required to have a constant influx of vaccine updates in order to maintain our Covid-19 immunity, it could come at an extraordinary price. Nobody (that I've seen) is talking about the ongoing energy requirements and the impact it will have on our health.

That's the first subject. The second is that I want to point out that J&J is employing fairly standard technology for its vaccine - which is why J&J stock has only risen from 149 to 162 in the last year. You'd expect better, much better, if it was about to introduce a wonderful vaccine that everyone in the world is going to use AND had some sort of monopoly on it.

Similarly, Pfizer and Moderna have produced their drugs (note that I'm resisting the urge to call them vaccines) using mRNA technology. HOWEVER, I don't believe either company has landbreak patents that keep any of the 100+ other companies experimenting in the field from swooping in and stealing their thunder on any given day. Yes, they're the two that have drugs out today, but I think the value of what they've done... particularly what Moderna has done... may be badly overestimated by investors. MRNA has a market cap of 69 billion dollars... which is crazy if they don't have a huge technological advantage on competitors. Pfizer, at least, has a plethora of other products. And profits. Not so with Moderna.

Novavax (NVAX) is different. It truly does own some landbreaking technology, technology that allows it to produce protein strands outside of eggs at a stunning rate. I'm sure you know that patients who have egg allergies... or mercury sensitivity... or formaldehyde sensitivivty... sometimes react badly to standard vaccines. This probably won't be the case with those produced by Novavax. Novavax has come up with a method for growing protein strands on silicon wafers in the lab, then turning them into a vaccine. No eggs = no allergies, no formaldahyde, no mercury.

If you have money to invest, you might want to plunk some into Novavax. The stock isn't cheap and the company already has an 18 billion dollar market cap. But the likelihood that it will own the industry in a few years is tremendous.

Just my thoughts, for what they're worth.

- De




Avatar

Gold is $1,581/oz today. When it hits $2,000, it will be up 26.5%. Let's see how long that takes. - De 3/11/2013 - ANSWER: 7 Years, 5 Months


 - - - - -
View Replies (1) »



» You can also:
« 6TH POPE Home | Email msg. | Reply to msg. | Post new | Board info. Previous | Home | Next